The Circulating Cell-Free Tumor DNA Market is estimated to be valued at US$ 6.1 billion in 2023 and is expected to exhibit a CAGR of 22.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Circulating cell-free tumor DNA (ctDNA) refers to the DNA fragments released into the bloodstream by cancerous tumors. This market...